PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
{{output}}
BCL-XL is an anti-apoptotic protein that plays an important role in tumorigenesis, metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-XL has also been identified as a key survival factor in senescent cells. Accumulation of ... ...
